Rational Therapeutics Release: Targeted Cancer Therapy Improved with Ex-Vivo Chemosensitivity Analysis  
6/1/2007 1:36:40 PM

LONG BEACH, Calif. & CHICAGO--(BUSINESS WIRE)--Researchers at Rational Therapeutics (Long Beach, Calif.) have reported clinical results obtained with a laboratory technique (Ex-Vivo Analysis of Programmed Cell Death – EVA-PCD™) that accurately identifies patients who are candidates for targeted cancer therapy.